Ignite Creation Date:
2024-05-06 @ 1:05 AM
Last Modification Date:
2024-10-26 @ 10:59 AM
Study NCT ID:
NCT01729663
Status:
UNKNOWN
Last Update Posted:
2015-09-02
First Post:
2012-11-14
Brief Title:
Phase IIIII Clinical Study CSF470 Plus BCG Plus GM-CSF vs IFN Alpha 2b in Stage IIB IIC and III Melanoma Patients
Sponsor:
Organization:
Laboratorio Pablo Cassará SRL